Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?
作者信息
Zhang Chao, Wang Fu-Sheng, Silvestre Jean-Sébastien, Arenzana-Seisdedos Fernando, Tang Hong
机构信息
Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
Inserm UMRS 970, Paris Centre de Recherche Cardiovasculaire (PARCC), 75737 Paris cedex 15, Cedex, France.
出版信息
Cell Mol Immunol. 2020 Jun;17(6):675-676. doi: 10.1038/s41423-020-0454-3. Epub 2020 May 12.
Abstract
摘要
相似文献
1
Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19?高血压导致的异常CD8 + T细胞激活是否与重症COVID - 19患者的心脏损伤有关？
Cell Mol Immunol. 2020 Jun;17(6):675-676. doi: 10.1038/s41423-020-0454-3. Epub 2020 May 12.
2
Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.急性严重急性呼吸综合征冠状病毒 2 感染损害树突状细胞和 T 细胞应答。
Immunity. 2020 Oct 13;53(4):864-877.e5. doi: 10.1016/j.immuni.2020.07.026. Epub 2020 Aug 4.
3
The Science Underlying COVID-19: Implications for the Cardiovascular System.新型冠状病毒肺炎相关科学：对心血管系统的影响。
Circulation. 2020 Jul 7;142(1):68-78. doi: 10.1161/CIRCULATIONAHA.120.047549. Epub 2020 Apr 15.
4
Long-term infection of SARS-CoV-2 changed the body's immune status.新冠病毒长期感染改变了人体的免疫状态。
Clin Immunol. 2020 Sep;218:108524. doi: 10.1016/j.clim.2020.108524. Epub 2020 Jul 11.
5
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
6
COVID-19, Immuno-oncology and Cardiovascular Disease: Viewpoint from the Intersection.2019冠状病毒病、免疫肿瘤学与心血管疾病：交叉领域的观点
J Cardiovasc Transl Res. 2020 Jun;13(3):347-348. doi: 10.1007/s12265-020-10013-8.
7
CAPACITY-COVID: a European Registry to determine the role of cardiovascular disease in the COVID-19 pandemic.CAPACITY-COVID：一项欧洲登记研究，旨在确定心血管疾病在新冠疫情中的作用。
Eur Heart J. 2020 May 14;41(19):1795-1796. doi: 10.1093/eurheartj/ehaa280.
8
Severe COVID-19 is associated with deep and sustained multifaceted cellular immunosuppression.重症新型冠状病毒肺炎与深度且持续的多方面细胞免疫抑制有关。
Intensive Care Med. 2020 Sep;46(9):1769-1771. doi: 10.1007/s00134-020-06127-x. Epub 2020 Jun 8.
9
An Acute Respiratory Infection Runs Into the Most Common Noncommunicable Epidemic-COVID-19 and Cardiovascular Diseases.一种急性呼吸道感染遭遇了最常见的非传染性流行病——新冠肺炎与心血管疾病。
JAMA Cardiol. 2020 Jul 1;5(7):743-744. doi: 10.1001/jamacardio.2020.0934.
10
Fear of Coronavirus Disease 2019-An Emerging Cardiac Risk.对2019冠状病毒病的恐惧——一种新出现的心脏风险。
JAMA Cardiol. 2020 Sep 1;5(9):981-982. doi: 10.1001/jamacardio.2020.2890.
引用本文的文献
1
Severe invasive streptococcal infection in a patient with COVID-19: A case report.1例新冠肺炎患者的严重侵袭性链球菌感染：病例报告
IDCases. 2025 Jan 28;39:e02169. doi: 10.1016/j.idcr.2025.e02169. eCollection 2025.
2
Changes of Damage Associated Molecular Patterns in COVID-19 Patients.新冠病毒肺炎患者中损伤相关分子模式的变化
Infect Dis Immun. 2021 Apr 20;1(1):20-27. doi: 10.1097/01.ID9.0000733572.40970.6c. eCollection 2021 Apr.
3
T Cell Response to SARS-CoV-2 Coinfection and Comorbidities.T细胞对SARS-CoV-2合并感染及合并症的反应。
Pathogens. 2023 Feb 15;12(2):321. doi: 10.3390/pathogens12020321.
4
SARS-CoV-2 and Hypertension: Evidence Supporting Invasion into the Brain Via Baroreflex Circuitry and the Role of Imbalanced Renin-Angiotensin-Aldosterone-System.严重急性呼吸综合征冠状病毒2与高血压：支持通过压力反射回路侵入大脑的证据以及肾素-血管紧张素-醛固酮系统失衡的作用
Neurosci Insights. 2023 Feb 1;18:26331055231151926. doi: 10.1177/26331055231151926. eCollection 2023.
5
A Suspected Case of COVID-19-Induced Immunosuppression.一例疑似新型冠状病毒肺炎所致免疫抑制病例。
Cureus. 2022 Dec 5;14(12):e32227. doi: 10.7759/cureus.32227. eCollection 2022 Dec.
6
Peripheral T cell lymphopenia in COVID-19: potential mechanisms and impact.新型冠状病毒肺炎中的外周血T细胞淋巴细胞减少：潜在机制及影响
Immunother Adv. 2021 Jul 2;1(1):ltab015. doi: 10.1093/immadv/ltab015. eCollection 2021 Jan.
7
Association of cardiac injury with hypertension in hospitalized patients with COVID-19 in China.中国住院 COVID-19 患者中心脏损伤与高血压的相关性。
Sci Rep. 2021 Nov 17;11(1):22389. doi: 10.1038/s41598-021-01796-0.
8
Cardiovascular Disease Complicating COVID-19 in the Elderly.老年 COVID-19 合并心血管疾病。
Medicina (Kaunas). 2021 Aug 17;57(8):833. doi: 10.3390/medicina57080833.
9
Factors related to asymptomatic or severe COVID-19 infection.与无症状或重症 COVID-19 感染相关的因素。
Med Hypotheses. 2020 Nov;144:110296. doi: 10.1016/j.mehy.2020.110296. Epub 2020 Sep 24.
10
Aging in COVID-19: Vulnerability, immunity and intervention.COVID-19 相关衰老问题：脆弱性、免疫与干预。
Ageing Res Rev. 2021 Jan;65:101205. doi: 10.1016/j.arr.2020.101205. Epub 2020 Oct 31.
本文引用的文献
1
Kidney disease is associated with in-hospital death of patients with COVID-19.肾病与 COVID-19 患者住院期间的死亡相关。
Kidney Int. 2020 May;97(5):829-838. doi: 10.1016/j.kint.2020.03.005. Epub 2020 Mar 20.
2
Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers.2019冠状病毒病（COVID-19）感染与肾素-血管紧张素系统阻滞剂
JAMA Cardiol. 2020 Jul 1;5(7):745-747. doi: 10.1001/jamacardio.2020.1282.
3
[A pathological report of three COVID-19 cases by minimal invasive autopsies].[三例新冠病毒病病例微创尸检病理报告]
Zhonghua Bing Li Xue Za Zhi. 2020 May 8;49(5):411-417. doi: 10.3760/cma.j.cn112151-20200312-00193.
4
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
5
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
8
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
9
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.与急性呼吸窘迫综合征相关的新型冠状病毒肺炎的病理表现
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
10
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.从 2019 年新冠病毒感染患者中提取的临床和生化指标与病毒载量和肺部损伤有关。
Sci China Life Sci. 2020 Mar;63(3):364-374. doi: 10.1007/s11427-020-1643-8. Epub 2020 Feb 9.
Zotero 插件